Kemnay Advisory Services’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
ACA
Kemnay Advisory Services's CYTK Position: Q2 2026 in Review
Kemnay Advisory Services increased its Cytokinetics (CYTK) stake by 15% in Q2 2026, buying an estimated $10.8K and bringing the position to 1,164 shares worth $99.2K. The position accounts for 0.01% of the portfolio, ranked #167.
Kemnay Advisory Services first reported a position in CYTK in Q4 2025 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Kemnay Advisory Services held 1,164 shares of Cytokinetics worth $99.2K as of Q2 2026.
- Kemnay Advisory Services bought 151 Cytokinetics shares in Q2 2026, an estimated $10.8K.
- Cytokinetics made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #167 holding.
- Kemnay Advisory Services first reported a position in Cytokinetics in Q4 2025 and has held it in 3 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.